|
T77523 |
ALR2-IN-1
|
|
Reductase
|
|
ALR2-IN-1 is a potent and selective ALR2 inhibitor with an IC50 value of 1.42 μM.ALR2-IN-1 possesses both antiglycemic and antioxidant activities and can be used to study the complications of diabetes. |
|
T73305 |
ALR2-IN-3
|
|
|
|
ALR2-IN-2, a potent aldose reductase (ALR2) inhibitor, demonstrates IC50 values of 22 nM for rat ALR2 and 116 nM for ALR1, respectively. This compound is utilized in diabetic complications research. |
|
T73304 |
ALR2-IN-2
|
|
|
|
ALR2-IN-2, a potent aldose reductase (ALR2) inhibitor, exhibits IC50 values of 27 nM for rat ALR2 and 228 nM for ALR1, respectively. This compound is utilized in the research of diabetic complications. |
|
T2013 |
Ponalrestat
|
|
Reductase
|
|
Ponalrestat is an aldose reductase inhibitor. |
|
T27583 |
IDD388
|
IDD-388,IDD 388 |
DNA/RNA Synthesis
|
|
IDD388 is a selective and potent aldose reductase (ALR2) inhibitor with antitumor activity that inhibits the ALR1 receptor. |
|
T7478 |
2-Chloro-1-(4-fluorobenzyl)benzimidazole
|
|
Reductase
|
|
2-Chloro-1-(4-fluorobenzyl)benzimidazole is an inhibitor of aldose reductase (ALR2). |
|
T60897 |
Aldose reductase-IN-5
|
|
|
|
Aldose reductase-IN-5 is an inhibitor of aldose reductase (ALR2) that enhances the combination of inhibitory excitability and antioxidant capacity, thereby delaying the diabetes complications progress. |
|
T62456 |
ALR1/2-IN-1
|
|
|
|
ALR1/2-IN-1 (Compound 6e) is an aldehyde reductase (ALR1) (IC50: 3.26 μM) and aldose reductase (ALR2) (IC50: 3.06 μM) inhibitor with anticancer effects. |
|
T60601 |
Aldose reductase-IN-4
|
|
|
|
Aldose reductase-IN-4 (compund IIc) is an inhibitor of aldose reductase with IC50s of 11.70 μM and 0.98 μM for ALR1 and ALR2, respectively [1]. |
